How to prepare and submit a manuscript, what is required, and what to expect after you submit.
We encourage you to submit your manuscript through the OJS platform, as it keeps the publication process transparent and visible. All first-time users need to register themselves. Registration is free. Once registered, authors can use their username and password to submit and track their articles.
editor.ijphrd@gmail.com.Both forms are mandatory. Manuscripts without the cover letter or the copyright form are not considered for review.
All authors are advised to read the following policies first, before submitting an article to the journal, and to agree to them.
Authors who publish with this journal agree to the following terms:
We refer to the ICMJE guidelines to define authorship and contributorship. All authors are required to have made significant contributions to the intellectual content of the paper and meet at least one condition in each of the four categories of contributions:
Authors must ensure that all individuals who have made substantial contributions to the work reported in the manuscript (e.g., data collection, writing, or editing assistance) but do not meet the authorship criteria are named in an acknowledgement section within the manuscript. Authors must also confirm that all individuals named in the acknowledgement section have provided written permission to be named.
By submitting your manuscript to this journal, you affirm that both you and the other authors linked to the manuscript adhere to the criteria for authorship.
A conflict of interest arises in a manuscript when the author is associated with activities that might unduly influence their judgment, regardless of whether this influence occurs. Financial connections with industry, such as employment, consultancies, stock ownership, honoraria, grants, or expert testimony, either personally or through immediate family, are typically regarded as significant competing interests. Should such conflicts exist, authors are required to disclose them during manuscript submission.
The utilisation of Artificial Intelligence (AI) technologies, specifically Large Language Models (LLMs) like ChatGPT, is allowed solely for the enhancement of language and not for deriving insights and/or commentary. This usage must be thoroughly documented in the methods section. It is imperative that AI is not credited or listed as an author.
All studies involving human and animal subjects must address ethical considerations.
All studies involving animals must comply with recognised ethical and regulatory standards governing animal care and use. Authors should ensure adherence to applicable national guidelines, such as the NACLAR Guidelines (Singapore), NIH Guide for the Care and Use of Laboratory Animals (U.S.), or equivalent frameworks. Ethical approval must be obtained from an Institutional Animal Care and Use Committee (IACUC) or equivalent ethics body before the research begins, and details of this approval should be stated in the manuscript.
Reporting of animal experiments must follow the ARRIVE (Animal Research: Reporting of In Vivo Experiments) Guidelines to ensure transparency and reproducibility. The Editorial Board reserves the right to request evidence of ethical approval and ARRIVE compliance at any stage of submission, review, or publication. Failure to provide this documentation may lead to rejection of the manuscript.
In the case of identifiable photographs and/or medical data of research subjects, particularly minors and the deceased, informed consent should be obtained from the subject themselves, legal guardians or next of kin, respectively. The consent form is available below. The identity of the patient in clinical photographs should be masked by suitable methods, and any sensitive medical data should be anonymised.
Authors must disclose all financial and material support received for the research, providing details such as grant number and funding agency.
A submitted manuscript can be original research, a case report or a review article. For guidelines on the types of articles, see the document below.
A Word template with the recommended manuscript format is available below.
Given the extensive reach of IJPHRD, authors are advised to address the following questions to ensure their research resonates with a diverse audience, including community medicine professionals, social workers, and policymakers. Clear takeaways from the research will improve its relevance and citability. Authors are requested to address and summarise each of these in the Discussion/Conclusion section.
By addressing these key points, authors can significantly enhance the impact and clarity of their research, making it more valuable to the public health community and beyond.
A manuscript will be reviewed for possible publication with the understanding that it is being submitted exclusively to IJPHRD and has not been published, simultaneously submitted, or accepted for publication elsewhere. The journal requires that authors authorise one among them (the corresponding author) to communicate with the journal regarding all matters related to the manuscript. All received manuscripts are duly acknowledged.
Upon submission, editors initially review all manuscripts for suitability for formal review. Manuscripts may be rejected at this stage if they lack originality, have serious scientific or technical flaws, fail to convey a significant message, lack public health relevance, or do not conform to the journal's guidelines. The initial screening decision will typically be communicated within one week of submission completion.
Including the epidemiology of clinical conditions and/or the prevalence of psycho-social conditions is mandatory.
We are dedicated to upholding high editorial standards and maintaining the integrity of our journal. Our commitment to quality is reflected in our rigorous peer review process, which typically takes 4–5 weeks. Here is an overview of the evaluation process your manuscript will undergo after submission:
We encourage you to submit the manuscript through the OJS platform, as it maintains transparency and visibility of the publication process. If you are unable to submit on OJS, you can email your manuscript to editor.ijphrd@gmail.com.
If your article aligns with the journal's scope, it will proceed. Otherwise, the editor may suggest incorporating a relevant lens or may reject your article.
Rejection reasons:
Upon the editor's approval, a double-blind peer review will be initiated, involving subject matter experts. Following the review, your manuscript will be returned with comments.
Implement the necessary revisions based on the peer review comments and resubmit the revised manuscript to the editor.
If the editor is satisfied, you will be informed of your manuscript's acceptance, along with details about the publication timeline. Manuscript handling charges will be required, and an acceptance letter will be issued.
Before publication, you will receive a pre-release version of your article. Please review it thoroughly and communicate any essential changes to us.
We require an anonymised manuscript for our double-blind peer review process, meaning that author information will be concealed from peer reviewers. When submitting your manuscript, please eliminate any identifying details, such as authors' names or affiliations. Additionally, ensure that the manuscript is appropriately prepared for double-blind review by following these guidelines:
Once an article has been submitted and the review process is underway, changes to authorship are discouraged. If a change to the authors or their order is needed before publication, we require explicit consent from all the authors. This consent should be provided either through official email addresses or by submitting a no-objection certificate on their institution's letterhead.
If there is a change in authorship or contributorship after publication, we will follow the same process of requiring explicit consent from all authors. We can make the authorship and contributorship changes on platforms controlled by us, primarily the journal website and OJS, but we cannot guarantee that the changes will be reflected on third-party platforms and databases that index the journal.
You can withdraw your article at any time before publication. However, we may not be able to issue a full refund, especially if your article has been through the review process, since we have invested resources in the review. We will evaluate refunds on a case-by-case basis and may issue refunds to authors under financial duress. We recommend that you inform us about your intention to withdraw as soon as possible.
We operate open access publications, which means we do not charge for online subscriptions to our journal. Our primary goal is to establish high-quality multidisciplinary research platforms. The deliberate choice of an open-access model is driven by the intention to eliminate cost barriers for researchers, especially those based in developing countries, enabling unrestricted access to top-tier research.
To sustain the quality of our journal, nominal publication fees are charged to authors. These fees contribute to covering essential costs associated with maintaining a high-standard publication. Key expense areas include:
| Article category | Indian and South Asian authors | Foreign authors |
|---|---|---|
| Original research, systematic reviews, narrative reviews | ₹5,000 | USD 100 |
| Case reports, short communications, letters to the editor, policy briefs | ₹3,000 | USD 50 |
There is no submission fee. Charges apply only if an article is accepted.
While we typically do not offer fee waivers or discounts, owing to these operational costs, we recognise that researchers, particularly in developing countries, may face financial constraints. In light of this, we are open to considering waivers and discounts on a case-by-case basis.
If financial considerations may pose challenges for you, we encourage you to reach out to us and explain your circumstances. We have previously granted fee waivers to researchers facing conditions such as: